Valuation: Lotus Eye Hospital and Institute Limited

Capitalization 2.04B 21.29M 18.32M 16.75M 15.98M 29.3M 29.78M 201M 77.76M 970M 79.9M 78.19M 3.38B P/E ratio 2024
39.8x
P/E ratio 2025 186x
Enterprise value 2.04B 21.23M 18.27M 16.71M 15.94M 29.22M 29.7M 200M 77.56M 967M 79.68M 77.98M 3.37B EV / Sales 2024
2.28x
EV / Sales 2025 2.8x
Free-Float
28.06%
Yield 2024 *
-
Yield 2025 -
Mar. 17 Lotus Eye Hospital and Institute decides not to proceed with voluntary delisting from NSE RE
Feb. 26 Sangeetha Sundaramoorthy completed the acquisition of 6.87% stake in Lotus Eye Hospital and Institute Limited from Kavetha Sundaramoorthy for approximately INR 100 million. CI
Feb. 11 Lotus Eye Hospital and Institute Limited Appoints Mr. Prathish S. as Company Secretary and Compliance Officer, Effective February 13, 2026 CI
Feb. 10 Lotus Eye Hospital and Institute Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
Feb. 09 Lotus Eye Hospital and Institute Limited Announces Resignation of M Achuth Menon as Company Secretary & Compliance Officer, with Effect from Close of Business Hours on 12 February 2026 CI
Nov. 12 Lotus Eye Hospital and Institute Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-08-12 Lotus Eye Hospital and Institute Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-29 Lotus Eye Hospital and Institute Limited Announces Resignation of K S Ramalingam as Chief Executive Officer, Effective May 29, 2025 CI
25-05-29 Lotus Eye Hospital and Institute Limited Announces Resignation of K S Ramalingam as Whole Time Director, Effective May 29, 2025 CI
25-02-12 Lotus Eye Hospital and Institute Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
24-09-25 Lotus Eye Hospital and Institute Limited Announces Directorate Cessations CI
24-06-12 Lotus Eye Hospital and Institute Opens New Center in Tamil Nadu, India MT
24-05-27 Lotus Eye Hospital and Institute Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
1 day-4.06%
1 week-8.45%
Current month-10.36%
1 month-2.47%
3 months-10.25%
6 months-3.77%
Current year-10.63%
1 week 105.15
Extreme 105.15
116.49
1 month 105.15
Extreme 105.15
129.79
Current year 97.59
Extreme 97.59
147
1 year 67.72
Extreme 67.72
147
3 years 48.5
Extreme 48.5
147
5 years 38.25
Extreme 38.25
147
10 years 14.45
Extreme 14.45
147
Manager TitleAgeSince
Director of Finance/CFO 68 2022-05-24
Compliance Officer - 2026-02-12
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member 49 2009-12-23
Chairman 50 2020-11-10
Director/Board Member 76 2021-02-09
Change 5d. change 1-year change 3-years change Capi.($)
-4.06%-8.45%+42.40%+45.47% 23.1M
+0.22%+1.69%+28.96%+52.70% 20.22B
-1.86%+0.28%-17.02%-53.72% 14.45B
-0.45%-0.18%+15.22%+77.44% 12.11B
-0.62%+0.51%-11.77%+76.82% 10.58B
-0.89%+3.63%+18.64%+94.71% 10.3B
-1.08%-0.54%-22.13%-37.97% 8.9B
-0.72%+1.19%+37.65%+249.72% 7.58B
-0.95%-1.88%-22.59% - 6.32B
+3.47%+1.98%+4.07%-38.16% 6.17B
Average -0.69%-0.33%+7.34%+51.89% 9.67B
Weighted average by Cap. -0.45%+0.64%+5.83%+48.00%

Financials

2024 2025
Net sales 482M 5.02M 4.32M 3.95M 3.77M 6.92M 7.03M 47.43M 18.35M 229M 18.86M 18.45M 797M 496M 5.17M 4.45M 4.06M 3.88M 7.11M 7.23M 48.76M 18.87M 235M 19.39M 18.97M 820M
Net income 29.14M 304K 261K 239K 228K 418K 425K 2.87M 1.11M 13.84M 1.14M 1.12M 48.2M 7.39M 77.06K 66.31K 60.63K 57.84K 106K 108K 727K 281K 3.51M 289K 283K 12.23M
Net Debt -58.19M -607K -522K -477K -455K -835K -848K -5.73M -2.22M -27.62M -2.28M -2.23M -96.24M -5.48M -57.09K -49.12K -44.91K -42.85K -78.56K -79.86K -539K -209K -2.6M -214K -210K -9.06M
Logo Lotus Eye Hospital and Institute Limited
Lotus Eye Hospital and Institute Limited is an India-based company, which is engaged in the business of healthcare activities. The Company is engaged in the field of ophthalmology (eye) and its related operations. It resolves a range of eye problems, such as refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, UVEA and ocular inflammation, zyoptix-ultimate, and binocular vision. The Company provides various treatments, suchas ReLEx SMILE, Touchfree Laser, Lasik Eye Surgery, Epi-LASIK, Intralase, Supracor, Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, Paediatric Eye Care and Squint Surgery, and Micro Incision Cataract Surgery (MICS). The Company operates in various locations, such as Sitra, Coimbatore; RS Puram, Coimbatore; Salem; Tirupur; Mettupalayam; Kochi; Mulanthuruthy; Saravanampatty, and Karur.
Employees
348
Date Price Change Volume
26-05-15 106.56 -4.06% 15,573
26-05-14 111.07 +2.47% 12,679
26-05-13 108.39 -5.47% 21,370
26-05-12 114.66 +1.83% 12,315
26-05-11 112.60 -3.26% 7,775
  1. Stock Market
  2. Equities
  3. LOTUSEYE Stock